awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36613525-62961A8E-4691-48C7-AE98-1FE3D08BDA84
Q36613525-62961A8E-4691-48C7-AE98-1FE3D08BDA84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36613525-62961A8E-4691-48C7-AE98-1FE3D08BDA84
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancer.
P2860
Q36613525-62961A8E-4691-48C7-AE98-1FE3D08BDA84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36613525-62961A8E-4691-48C7-AE98-1FE3D08BDA84
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3aeb65d0ce6ad7a61660e3bf7b5cf653b3a5b196
P2860
Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.